Kurt Olson

3.8k total citations
38 papers, 1.9k citations indexed

About

Kurt Olson is a scholar working on Nephrology, Hematology and Psychiatry and Mental health. According to data from OpenAlex, Kurt Olson has authored 38 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Nephrology, 6 papers in Hematology and 5 papers in Psychiatry and Mental health. Recurrent topics in Kurt Olson's work include Parathyroid Disorders and Treatments (6 papers), Dialysis and Renal Disease Management (5 papers) and Erythropoietin and Anemia Treatment (5 papers). Kurt Olson is often cited by papers focused on Parathyroid Disorders and Treatments (6 papers), Dialysis and Renal Disease Management (5 papers) and Erythropoietin and Anemia Treatment (5 papers). Kurt Olson collaborates with scholars based in United States, United Kingdom and Australia. Kurt Olson's co-authors include Preston Klassen, Glenn M. Chertow, John Cunningham, Mark D. Danese, Peter A. Ahmann, Dean Stueland, David L. Nordstrom, Geoffrey A. Block, Marc E. Key and Thayer C. French and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Clinical Endocrinology & Metabolism and Neurology.

In The Last Decade

Kurt Olson

37 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kurt Olson United States 20 982 298 296 233 214 38 1.9k
Christian Bieglmayer Austria 31 669 0.7× 232 0.8× 296 1.0× 368 1.6× 305 1.4× 109 3.1k
Pierre Bergmann Belgium 27 261 0.3× 305 1.0× 118 0.4× 471 2.0× 184 0.9× 110 2.1k
Danuta Zwołińska Poland 20 504 0.5× 92 0.3× 122 0.4× 363 1.6× 157 0.7× 147 1.6k
Rajata Rajatanavin Thailand 30 212 0.2× 371 1.2× 187 0.6× 705 3.0× 178 0.8× 115 3.1k
Dina Appleby United States 15 870 0.9× 270 0.9× 330 1.1× 238 1.0× 222 1.0× 32 1.7k
Richard Keen United Kingdom 31 288 0.3× 564 1.9× 165 0.6× 673 2.9× 232 1.1× 92 2.8k
Christine Simpson United States 19 342 0.3× 229 0.8× 173 0.6× 239 1.0× 118 0.6× 49 1.3k
Seong‐Kyu Kim South Korea 29 497 0.5× 268 0.9× 52 0.2× 651 2.8× 140 0.7× 140 2.5k
G. Gamble New Zealand 25 367 0.4× 163 0.5× 89 0.3× 372 1.6× 231 1.1× 53 2.1k
Roy A. Kaplan United States 18 431 0.4× 289 1.0× 170 0.6× 244 1.0× 444 2.1× 26 2.1k

Countries citing papers authored by Kurt Olson

Since Specialization
Citations

This map shows the geographic impact of Kurt Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt Olson more than expected).

Fields of papers citing papers by Kurt Olson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt Olson. The network helps show where Kurt Olson may publish in the future.

Co-authorship network of co-authors of Kurt Olson

This figure shows the co-authorship network connecting the top 25 collaborators of Kurt Olson. A scholar is included among the top collaborators of Kurt Olson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurt Olson. Kurt Olson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
LeWitt, Peter A., Grace Liang, C. Warren Olanow, et al.. (2023). Opicapone Pharmacokinetics and Effects on Catechol-O-Methyltransferase Activity and Levodopa Pharmacokinetics in Patients With Parkinson Disease Receiving Carbidopa/Levodopa. Clinical Neuropharmacology. 46(2). 43–50. 1 indexed citations
2.
Lew, Mark, Robert A. Hauser, Stuart Isaacson, et al.. (2020). Efficacy of Opicapone Compared to Entacapone in Parkinson’s Patients with Motor Fluctuations and ON Hoehn & Yahr ≤ 2.5: A Post Hoc Analysis of BIPARK-1 (4429). Neurology. 94(15_supplement). 1 indexed citations
3.
Olson, Kurt, et al.. (2018). 1145: CLINICAL DECISION SUPPORT SYSTEM TO LOCATE MECHANICALLY VENTILATED PATIENTS WITH HIGH-RISK MORTALITY. Critical Care Medicine. 47(1). 549–549. 1 indexed citations
4.
Warady, Bradley A., John Barcia, Nadine Benador, et al.. (2017). De novo weekly and biweekly darbepoetin alfa dosing in pediatric patients with chronic kidney disease. Pediatric Nephrology. 33(1). 125–137. 8 indexed citations
5.
Bello, Natalie A., Eldrin F. Lewis, Akshay S. Desai, et al.. (2015). Increased Risk of Stroke with Darbepoetin Alfa in Anaemic Heart Failure Patients with Diabetes and Chronic Kidney Disease. European Journal of Heart Failure. 17(11). 1201–1207. 34 indexed citations
6.
Olson, Kurt, et al.. (2011). Long-term prognosis associated with J-point elevation in a large middle-aged biracial cohort: the ARIC study. European Heart Journal. 32(24). 3098–3106. 99 indexed citations
7.
Chertow, Glenn M., Lara B. Pupim, Geoffrey A. Block, et al.. (2007). Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE). Clinical Journal of the American Society of Nephrology. 2(5). 898–905. 120 indexed citations
8.
Bahner, Udo, A. P. S. Disney, Stephen Soroka, et al.. (2007). Cinacalcet HCl (Sensipar/ Mimpara) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidism. Clinical Nephrology. 68(7). 10–17. 41 indexed citations
9.
Cunningham, John, Mark D. Danese, Kurt Olson, Preston Klassen, & Glenn M. Chertow. (2005). Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney International. 68(4). 1793–1800. 376 indexed citations
10.
Moe, Sharon M., Glenn M. Chertow, Jack W. Coburn, et al.. (2005). Achieving NKF-K/DOQI™ bone metabolism and disease treatment goals with cinacalcet HCl. Kidney International. 67(2). 760–771. 236 indexed citations
11.
Moe, Sharon M., J. W. Coburn, L. Darryl Quarles, et al.. (2003). Achievement of proposed NKF-K/DOQI Bone Metabolism and Disease targets Treatment with cinacalcet HCl in dialysis patients with uncontrolled secondary hyperparathyroidism. 48. 5 indexed citations
12.
Meier, Paul, et al.. (2003). Prevention of Iron Deficiency Anemia in Adolescent and Adult Pregnancies. Clinical Medicine & Research. 1(1). 29–36. 73 indexed citations
13.
Lerner, Gary, Arundhati S. Kale, Bradley A. Warady, et al.. (2002). Pharmacokinetics of darbepoetin alfa in pediatric patients with chronic kidney disease. Pediatric Nephrology. 17(11). 933–937. 44 indexed citations
14.
Nordstrom, David L., et al.. (1996). Animal-related Occupational Injuries in Farm Residents. Journal of Agricultural Safety and Health. 2(1). 27–37. 30 indexed citations
15.
Layde, Peter M., et al.. (1995). Machine-related occupational injuries in farm residents. Annals of Epidemiology. 5(6). 419–426. 52 indexed citations
16.
Nordstrom, David L., et al.. (1995). Incidence of farm‐work–related acute injury in a defined population. American Journal of Industrial Medicine. 28(4). 551–564. 59 indexed citations
17.
Ahmann, Peter A., et al.. (1993). Placebo-Controlled Evaluation of Ritalin Side Effects. PEDIATRICS. 91(6). 1101–1106. 142 indexed citations
18.
Wahls, Terry L., et al.. (1993). Practice satisfaction and dissatisfaction in general internal medicine departments of large multispecialty clinics. Journal of General Internal Medicine. 8(10). 578–579. 11 indexed citations
19.
So, Elson L., Kevin H. Ruggles, Peter A. Ahmann, & Kurt Olson. (1993). Prognosis of photoparoxysmal response in nonepileptic patients. Neurology. 43(9). 1719–1719. 21 indexed citations
20.
Jacobson, Daniel M. & Kurt Olson. (1991). Impaired critical flicker frequency in recovered optic neuritis. Annals of Neurology. 30(2). 213–215. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Bieglmayer Breakdown of academic impact, for papers by Pierre Bergmann Breakdown of academic impact, for papers by Danuta Zwołińska Breakdown of academic impact, for papers by Rajata Rajatanavin Breakdown of academic impact, for papers by Dina Appleby Breakdown of academic impact, for papers by Richard Keen Breakdown of academic impact, for papers by Christine Simpson Breakdown of academic impact, for papers by Seong‐Kyu Kim Breakdown of academic impact, for papers by G. Gamble Breakdown of academic impact, for papers by Roy A. Kaplan
Rankless by CCL
2026